Literature DB >> 27034639

Pseudomonas aeruginosa bacteremia secondary to acute right leg cellulitis: case of community-acquired infection.

Asrul Abdul Wahab1, M M Rahman1.   

Abstract

Pseudomonas aeruginosa is a gram-negative bacillus that causes wide spectrum clinical infections. However, it is most frequently associated with hospital-acquired infection. In this case a 58-year-old male with underlying hypertension and dyslipidaemia was admitted for acute right leg cellulitis. Pseudomonas aeruginosa was identified from the case, though it was not a usual suspected organism. It might be due to community-acquired infection.

Entities:  

Keywords:  AmpC; Pseudomonas aeruginosa; bacteremia; cellulitis; community-acquired

Year:  2013        PMID: 27034639      PMCID: PMC4803009     

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


  9 in total

Review 1.  Skin and soft tissue infection: microbiology and epidemiology.

Authors:  Matthew S Dryden
Journal:  Int J Antimicrob Agents       Date:  2009-07       Impact factor: 5.283

2.  Clinical characteristics and risk factors for mortality in patients with bacteremia caused by Pseudomonas aeruginosa.

Authors:  Tetsuya Horino; Akio Chiba; Shinji Kawano; Tetsuro Kato; Fumiya Sato; Yukio Maruyama; Yasushi Nakazawa; Koji Yoshikawa; Masaki Yoshida; Seiji Hori
Journal:  Intern Med       Date:  2012-01-01       Impact factor: 1.271

3.  Therapeutic guidelines for Pseudomonas aeruginosa infections.

Authors:  H Giamarellou
Journal:  Int J Antimicrob Agents       Date:  2000-10       Impact factor: 5.283

4.  Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; Fe Tubau; María D Macia; Cristina Rodríguez; Bartolomé Moya; Laura Zamorano; Cristina Suárez; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

5.  Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.

Authors:  Astra Vitkauskienė; Erika Skrodenienė; Asta Dambrauskienė; Andrius Macas; Raimundas Sakalauskas
Journal:  Medicina (Kaunas)       Date:  2010       Impact factor: 2.430

6.  Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa.

Authors:  V H Tam; A N Schilling; M T LaRocco; L O Gentry; K Lolans; J P Quinn; K W Garey
Journal:  Clin Microbiol Infect       Date:  2007-04       Impact factor: 8.067

7.  Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection.

Authors:  M D Parkins; D B Gregson; J D D Pitout; T Ross; K B Laupland
Journal:  Infection       Date:  2009-12-12       Impact factor: 3.553

8.  Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.

Authors:  Vincent H Tam; Kai-Tai Chang; Amy N Schilling; Mark T LaRocco; Layne O Genty; Kevin W Garey
Journal:  Diagn Microbiol Infect Dis       Date:  2009-01-08       Impact factor: 2.803

9.  Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?

Authors:  Vered Schechner; Vandack Nobre; Keith S Kaye; Moshe Leshno; Michael Giladi; Peter Rohner; Stephan Harbarth; Deverick J Anderson; Adolf W Karchmer; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

  9 in total
  1 in total

1.  Human single-chain antibodies that neutralize Pseudomonas aeruginosa-exotoxin A-mediated cellular apoptosis.

Authors:  Sirijan Santajit; Watee Seesuay; Kodchakorn Mahasongkram; Nitat Sookrung; Sumate Ampawong; Onrapak Reamtong; Pornphan Diraphat; Wanpen Chaicumpa; Nitaya Indrawattana
Journal:  Sci Rep       Date:  2019-10-17       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.